HR 482 117th Congress House Health Child health Congressional oversight Drug safety, medical device, and laboratory regulation Genetics Government studies and investigations Health information and medical records Health promotion and preventive care Health technology, devices, supplies Medical ethics Medical research Medical tests and diagnostic methods State and local government operations

Newborn Screening Saves Lives Reauthorization Act of 2021

Introduced: January 25, 2021 See on congress.gov

Everywhere this bill has been 11 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jun 24, 2021

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Jun 23, 2021

Pursuant to section 11 of H. Res. 486, and the motion offered by Mr. McGovern, the following bills passed under suspension of the rules: H.R. 482; H.R. 704; H.R. 961, as amended; H.R. 1314; H.R. 2571, as amended; H.R. 2679, as amended; H.R. 2694; H.R. 2922, as amended; H.R. 3182; H.R. 3239; H.R. 3241, as amended; H.R. 3723; H.R. 3752; H.R. 3841; S. 409; and S. 1340. (consideration: CR H3026-3052; text: CR H3026-3027)

Jun 23, 2021

Passed/agreed to in House: Pursuant to section 11 of H. Res. 486, and the motion offered by Mr. McGovern, the following bills passed under suspension of the rules: H.R. 482; H.R. 704; H.R. 961, as amended; H.R. 1314; H.R. 2571, as amended; H.R. 2679, as amended; H.R. 2694; H.R. 2922, as amended; H.R. 3182; H.R. 3239; H.R. 3241, as amended; H.R. 3723; H.R. 3752; H.R. 3841; S. 409; and S. 1340.(consideration: CR H3026-3052; text: CR H3026-3027)

Jun 23, 2021

Pursuant to the provisions of H. Res. 486, proceedings on H.R. 482 are considered vacated.

Jun 22, 2021

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

Jun 22, 2021

DEBATE - The House proceeded with forty minutes of debate on H.R. 482.

Jun 22, 2021

Considered under suspension of the rules. (consideration: CR H2940-2942; text: CR H2940-2941)

Jun 22, 2021

Mr. Pallone moved to suspend the rules and pass the bill.

Feb 2, 2021

Referred to the Subcommittee on Health.

Jan 25, 2021

Referred to the House Committee on Energy and Commerce.

Jan 25, 2021

Introduced in House

Plain-English summary Congressional Research Service

Newborn Screening Saves Lives Reauthorization Act of 2021

This bill reauthorizes through FY2026 and revises several programs and activities relating to newborn screening for certain conditions and genetic, endocrine, and metabolic diseases.

Among its changes, the bill reauthorizes and makes mandatory

the Hunter Kelly Research Program at the National Institutes of Health, and
national surveillance activities conducted by the Centers for Disease Control and Prevention.

The bill also aligns statutory requirements for research on non-identified newborn blood spots with federal regulations governing research on human subjects. These blood spots are collected as part of newborn screening programs, and some states make them available for biomedical and public health research. Under current regulations, research on non-identified bio-specimens such as blood spots is not considered to be research on human subjects, to which additional protections apply.

What's happening now June 24, 2021

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committees of jurisdiction 3